Dr Tang has received speaker’s honoraria and served as a physician proctor, consultant, advisory board member, TAVR publications committee member, RESTORE study (Redo Transcatheter Aortic Valve Replacement for Transcatheter Aortic Valve Failure) steering committee member, APOLLO trial (Transcatheter Mitral Valve Replacement With the Medtronic Intrepid TMVR System in Patients With Severe Symptomatic Mitral Regurgitation) screening committee member, and IMPACT MR steering committee member for Medtronic. He has also received speaker’s honoraria and served as a physician proctor, consultant, advisory board member, and TRILUMINATE trial (Trial to Evaluate Treatment With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater Tricuspid Regurgitation) anatomic eligibility and publications committee member for Abbott Structural Heart. In addition, he has served as an advisory board member for Boston Scientific, a consultant and physician screening committee member for Shockwave Medical, a consultant for Philips, Edwards Lifesciences, Peija Medical, and Shenqi Medical Technology, and has received speaker’s honoraria from Siemens Healthineers. The other author report no conflicts.